Publikasi Scopus 2024 per tanggal 29 Februari 2024 (130 artikel)

Thng Z.X.; Putera I.; Testi I.; Chan K.; Westcott M.; Chee S.-P.; Dick A.D.; Kempen J.H.; Bodaghi B.; Thorne J.E.; Barisani-Asenbauer T.; de Smet M.D.; Smith J.R.; McCluskey P.; La Distia Nora R.; Jabs D.A.; de Boer J.H.; Sen H.N.; Goldstein D.A.; Khairallah M.; Davis J.L.; Rosenbaum J.T.; Jones N.P.; Nguyen Q.D.; Pavesio C.; Agrawal R.; Gupta V.; Thng Z.X.; Putera I.; Agrawal R.; Dick A.D.; Kempen J.H.; Zierhut M.; Smith J.R.; Boer J.; Sen H.N.; Goldstein D.A.; Davis J.L.; Nguyen Q.D.; Gupta V.; Palestine A.; Denniston A.K.; Invernizzi A.; Radgonde A.; Kumar A.; Curi A.; Agarwal A.; Sook Yee A.C.; Okada A.A.; Schlaen A.; Heiligenhaus A.; Gurbaxani A.; Murugan S.B.; Lee C.S.; Das D.; Baglivo E.; Carreño E.; Arevalo J.F.; Pichi F.; Uy H.; Al-Dhibi H.A.; Rosenbaum J.T.; Garweg J.G.; Biswas J.; Murthy K.B.; Caspers L.; Cimino L.; Lim L.L.; de la Maza M.S.; Agarwal M.; Mochizucki M.; Agarwal M.; Munk M.R.; Accorinti M.; Tyagi M.; Jones N.P.; Acharya N.; Mahendradas P.; Dutta Majumder P.; Murray P.I.; Lim P.; Neri P.; Bansal R.; Read R.W.; Mehta S.; Shoughy Shawki S.S.; Mazumdar S.; Narain S.; Androudi S.; Murthy S.; Rathinam S.R.; Beng S.T.C.; Sridharan S.; Phatak S.; Tappeiner C.; Lai T.Y.Y.; Yuen Y.S.; Feng Y.
Thng, Zheng Xian (57203372016); Putera, Ikhwanuliman (56485949000); Testi, Ilaria (57190493331); Chan, Kevin (58795039000); Westcott, Mark (7003910861); Chee, Soon-Phaik (7005885793); Dick, Andrew D. (7103296976); Kempen, John H. (6603842682); Bodaghi, Bahram (56244598700); Thorne, Jennifer E. (7102946118); Barisani-Asenbauer, Talin (6601921047); de Smet, Marc D. (7006682778); Smith, Justine R. (58500776600); McCluskey, Peter (55598660500); La Distia Nora, Rina (56001881000); Jabs, Douglas A. (7
57203372016; 56485949000; 57190493331; 58795039000; 7003910861; 7005885793; 7103296976; 6603842682; 56244598700; 7102946118; 6601921047; 7006682778; 58500776600; 55598660500; 56001881000; 7102589668; 7201921240; 7003412064; 7402147883; 7004503022; 7405960166; 57206434371; 56650499400; 55666336400; 7003495942; 7201475180; 35452834800; 58793593500; 58794315300; 58825687600; 57937699400; 57216598048; 57203252974; 7410169450; 58795274100; 58795039200; 57365013100; 57201655659; 58278021700; 58794075800; 7006252760; 54880010400; 36846060800; 58795274200; 58856292900; 6603554904; 57209565397; 57195331285; 7402333430; 6505774527; 7004464646; 16028184200; 57202223321; 56472056400; 35551118100; 6603901674; 36494045500; 58533545600; 53164582500; 6603825390; 8393725100; 58794565000; 7006639200; 7102648244; 57207751189; 8320551100; 7003872473; 15053336200; 58718744200; 20833248100; 58795039300; 57542422200; 54389904200; 6701349355; 54418168600; 58795039400; 15834058800; 58226086700; 56922253900; 35595791500; 58794315500; 16304917600; 7202185100; 7201365182; 9634993500; 58793593800; 57202781936; 16464738600; 6603286512; 7202013121; 57210661056; 58794565200; 12766892600; 24067663300; 25229140300; 7202203581; 57214457047; 57199165550
The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 2—global current practice patterns for the management of Cytomegalovirus anterior uveitis
2024
Eye (Basingstoke)
38
1
68
75
7
1
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia; Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Singapore National Eye Centre, Singapore, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; University of Bristol, Bristol, United Kingdom; UCL-Institute of Ophthalmology, London, United Kingdom; Department of Ophthalmology, Massachusetts Eye and Ear/Harvard Medical School; and Schepens Eye Research Institute, Boston, MA, United States; Sight for Souls, Fort Myers, FL, United States; Addis Ababa University Department of Ophthalmology, Addis Ababa, Ethiopia; MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital, and MyungSung Medical School, Addis Ababa, Ethiopia; Dept of Ophthalmology, IHU FOReSIGHT, Sorbonne-APHP, 47-83 bd de l’Hopital, Paris, 75013, France; Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; Dept of Ophthalmology, Leiden University, Leiden, Netherlands; MIOS sa, Lausanne, Switzerland; Flinders University College of Medicine & Public Health, Adelaide, Australia and Queensland Eye Institute, Brisbane, QLD, Australia; Department of Ophthalmology, Director Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; Department of Ophthalmology, Utrecht University Medical Center, Utrecht, Netherlands; National Eye Institute, National Institutes of Health, Bethesda, MD, United States; Northwestern University, Feinberg School of Medicine, Chicago, IL, United States; Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Oregon Health and Science University, Portland, OR, United States; Legacy Devers Eye Institute, Portland, OR, United States; School of Biological Sciences, University of Manchester, Manchester, United Kingdom; Byers Eye Institute, Stanford Medical School, Palo Alto, CA, United States; Duke NUS Medical School, Singapore, Singapore; Singapore Eye Research Institute, Singapore, Singapore; Advanced Eye Centre, Post-graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Thng Z.X., National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Putera I., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; Testi I., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Chan K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Westcott M., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Chee S.-P., Singapore National Eye Centre, Singapore, Singapore, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Dick A.D., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, University of Bristol, Bristol, United Kingdom, UCL-Institute of Ophthalmology, London, United Kingdom; Kempen J.H., Department of Ophthalmology, Massachusetts Eye and Ear/Harvard Medical School; and Schepens Eye Research Institute, Boston, MA, United States, Sight for Souls, Fort Myers, FL, United States, Addis Ababa University Department of Ophthalmology, Addis Ababa, Ethiopia, MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital, and MyungSung Medical School, Addis Ababa, Ethiopia; Bodaghi B., Dept of Ophthalmology, IHU FOReSIGHT, Sorbonne-APHP, 47-83 bd de l’Hopital, Paris, 75013, France; Thorne J.E., Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States, Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Barisani-Asenbauer T., Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; de Smet M.D., Dept of Ophthalmology, Leiden University, Leiden, Netherlands, MIOS sa, Lausanne, Switzerland; Smith J.R., Flinders University College of Medicine & Public Health, Adelaide, Australia and Queensland Eye Institute, Brisbane, QLD, Australia; McCluskey P., Department of Ophthalmology, Director Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; La Distia Nora R., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Jabs D.A., Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States, Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; de Boer J.H., Department of Ophthalmology, Utrecht University Medical Center, Utrecht, Netherlands; Sen H.N., National Eye Institute, National Institutes of Health, Bethesda, MD, United States; Goldstein D.A., Northwestern University, Feinberg School of Medicine, Chicago, IL, United States; Khairallah M., Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia; Davis J.L., Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Rosenbaum J.T., Oregon Health and Science University, Portland, OR, United States, Legacy Devers Eye Institute, Portland, OR, United States; Jones N.P., School of Biological Sciences, University of Manchester, Manchester, United Kingdom; Nguyen Q.D., Byers Eye Institute, Stanford Medical School, Palo Alto, CA, United States; Pavesio C., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, UCL-Institute of Ophthalmology, London, United Kingdom; Agrawal R., National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore, National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, Duke NUS Medical School, Singapore, Singapore, Singapore Eye Research Institute, Singapore, Singapore; Gupta V., Advanced Eye Centre, Post-graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Thng Z.X.; Putera I.; Agrawal R.; Dick A.D.; Kempen J.H.; Zierhut M.; Smith J.R.; Boer J.; Sen H.N.; Goldstein D.A.; Davis J.L.; Nguyen Q.D.; Gupta V.; Palestine A.; Denniston A.K.; Invernizzi A.; Radgonde A.; Kumar A.; Curi A.; Agarwal A.; Sook Yee A.C.; Okada A.A.; Schlaen A.; Heiligenhaus A.; Gurbaxani A.; Murugan S.B.; Lee C.S.; Das D.; Baglivo E.; Carreño E.; Arevalo J.F.; Pichi F.; Uy H.; Al-Dhibi H.A.; Rosenbaum J.T.; Garweg J.G.; Biswas J.; Murthy K.B.; Caspers L.; Cimino L.; Lim L.L.; de la Maza M.S.; Agarwal M.; Mochizucki M.; Agarwal M.; Munk M.R.; Accorinti M.; Tyagi M.; Jones N.P.; Acharya N.; Mahendradas P.; Dutta Majumder P.; Murray P.I.; Lim P.; Neri P.; Bansal R.; Read R.W.; Mehta S.; Shoughy Shawki S.S.; Mazumdar S.; Narain S.; Androudi S.; Murthy S.; Rathinam S.R.; Beng S.T.C.; Sridharan S.; Phatak S.; Tappeiner C.; Lai T.Y.Y.; Yuen Y.S.; Feng Y.
Aims: To present current practice patterns in the diagnosis and management of Cytomegalovirus anterior uveitis (CMV AU) by uveitis experts worldwide. Methods: A two-round modified Delphi survey with masking of the study team was performed. Based on experience and expertise, 100 international uveitis specialists from 21 countries were invited to participate in the survey. Variation in the diagnostic approaches and preferred management of CMV AU was captured using an online survey platform. Results: Seventy-five experts completed both surveys. Fifty-five of the 75 experts (73.3%) would always perform diagnostic aqueous tap in suspected CMV AU cases. Consensus was achieved for starting topical antiviral treatment (85% of experts). About half of the experts (48%) would only commence systemic antiviral treatment for severe, prolonged, or atypical presentation. The preferred specific route was ganciclovir gel 0.15% for topical treatment (selected by 70% of experts) and oral valganciclovir for systemic treatment (78% of experts). The majority of experts (77%) would commence treatment with topical corticosteroid four times daily for one to two weeks along with antiviral coverage, with subsequent adjustment depending on the clinical response. Prednisolone acetate 1% was the drug of choice (opted by 70% of experts). Long-term maintenance treatment (up to 12 months) can be considered for chronic course of inflammation (88% of experts) and those with at least 2 episodes of CMV AU within a year (75–88% of experts). Conclusions: Preferred management practices for CMV AU vary widely. Further research is necessary to refine diagnosis and management and provide higher-level evidence. © 2023, The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Antiviral Agents; Aqueous Humor; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Humans; Uveitis, Anterior; alpha adrenergic receptor stimulating agent; beta adrenergic receptor blocking agent; carbonate dehydratase inhibitor; corticosteroid; dexamethasone; fluorometholone; foscarnet; ganciclovir; gel; loteprednol; prednisolone acetate; prostaglandin; valganciclovir; antivirus agent; ganciclovir; adult; antiviral therapy; aqueous tap; Article; clinical assessment; clinical feature; clinical monitoring; clinical practice; controlled study; cornea edema; Cytomegalovirus; cytomegalovirus anterior uveitis; cytomegalovirus infection; data analysis; Delphi study; diagnostic test; disease course; disease severity; follow up; granulomatosis; health survey; human; inflammation; iridocycli
National Institutes of Health, NIH; Institute for Research on Poverty, IRP; National Medical Research Council, NMRC
HNS’s work is supported by the NIH Intramural research program (IRP). The funding organisation had no role in the design or conduct of this research. Rupesh Agrawal has received NMRC Clinician Scientist Award from National Medical Research Council, Singapore, but the funding organisation has no role in the design or conduct of this research.
Springer Nature
0950222X
37419958
Article
#N/A
#N/A
#N/A